Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,579,261
-
Total 13F shares
-
2,690,191
-
Share change
-
+237,955
-
Total reported value
-
$57,884,029
-
Price per share
-
$21.48
-
Number of holders
-
50
-
Value change
-
+$5,149,401
-
Number of buys
-
28
-
Number of sells
-
13
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q3 2017
As of 30 Sep 2017,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,690,191 shares.
The largest 10 holders included
MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, FLAGSHIP HARBOR ADVISORS, LLC, WELLS FARGO & COMPANY/MN, LPL Financial LLC, RAYMOND JAMES & ASSOCIATES, COHEN & STEERS INC, STEPHENS INC /AR/, UBS Group AG, and BLAIR WILLIAM & CO/IL.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.